Rankings
▼
Calendar
ZTS Q4 2019 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
Q4 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.7B
+7.0% YoY
Gross Profit
$1.1B
65.9% margin
Operating Income
$500M
29.9% margin
Net Income
$384M
22.9% margin
EPS (Diluted)
$0.80
QoQ Revenue Growth
+5.7%
Cash Flow
Operating Cash Flow
$582M
Free Cash Flow
$416M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$11.5B
Total Liabilities
$8.8B
Stockholders' Equity
$2.7B
Cash & Equivalents
$1.9B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.7B
$1.6B
+7.0%
Gross Profit
$1.1B
$981M
+12.5%
Operating Income
$500M
$436M
+14.7%
Net Income
$384M
$345M
+11.3%
Revenue Segments
Horses
$2.1B
58%
Cattle
$885M
24%
Swine
$320M
9%
Poultry
$285M
8%
Fish
$69M
2%
← FY 2019
All Quarters
Q1 2020 →